Pharmafit Provence
HUMEX FOURNIER 0,04 % S nasal powder Fl spray/15mL
Urgo Healthcare

HUMEX FOURNIER 0,04 % S nasal powder Fl spray/15mL

VIDAL information
OTC medicineNot reimbursedUnscheduled
Your professional account

PharmaFit supplies pharmacies and healthcare professionals. Access your purchasing terms and availability through your professional account.

Access is reserved for authorised professionals, following account approval.

Contact PharmaFit

Product information

Find indications, dosage and precautions in the sections below.

Automatic English translation of the French VIDAL document. Original numerical values and units are retained, including decimal commas.

VIDAL
Medicines
SmPC of the 08/06/2026

HUMEX FOURNIER 0,04 PERCENT, nasal spray solution


Forms and presentations

Solution for nasal spray.


Composition

Benzalkonium chloride.......................................................................................................................... 0,04 g

For 100 ml of nasal spray solution.


Excipients:

Cineole (eucalyptol), polysorbate 80, sodium chloride, citric acid monohydrate, sodium citrate, purified water.

 



Indications

Adjunctive local treatment of infections of the rhinopharyngeal mucosa.



Dosage and administration

Dosage

KEEP OUT OF REACH OF ADULTS AND CHILDREN OVER 30 MONTHS.

Adults: 1 to 2 sprays in each nostril 4 to 5 times a day.

Children over 30 months: 1 spray in each nostril 3 to 4 times a day.

Method of administration

Nasal sprays should be administered with the bottle in an upright position and the head slightly tilted forward, in order to avoid swallowing the product.



Contraindications

• Hypersensitivity to any of the constituents, in particular to quaternary ammoniums.

• Related to the presence of cineole as an excipient: children with a history of convulsions (febrile or not).



Warnings and precautions

Special warnings

This specialty contains cineole (a terpene derivative) as an excipient, which may lower the epileptogenic threshold. At excessive doses, risk of:

• convulsive-type accidents, in infants and children,

• breathing pauses and collapse in infants.

Respect the instructions for use and dosages, in particular: never exceed the recommended doses.

This medicine contains 0,04 g of benzalkonium chloride per 100 ml of nasal spray solution. Benzalkonium chloride may cause irritation or oedema of the nasal mucosa, particularly with long-term use.

Precautions for use

As soon as the container is opened, and even more so from the first use of a preparation for nasal use, microbial contamination is possible.

• The indication does not justify prolonged treatment.

• In the presence of associated general clinical signs, systemic treatment should be considered.

• In case of a history of epilepsy, take into account the presence of terpene derivatives as an excipient.



Interactions

The data available to date do not suggest the existence of clinically significant interactions.



Fertility, pregnancy and breastfeeding

In case of breastfeeding, it is preferable not to use this medicine due to:

• the absence of kinetic data on the passage of terpene derivatives into milk,

• and their potential neurological toxicity in infants.



Driving and using machines

HUMEX FOURNIER 0,04 PER CENT, nasal spray solution has no effect on the ability to drive vehicles and use machines.



Adverse effects

• Possibility of allergy.

• Local irritation.

• Due to the presence of cineole as an excipient and in case of not respecting the recommended doses:

  • risk of convulsions in children,
  • possibility of agitation, confusion in elderly subjects.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reaction via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Centres of Pharmacovigilance - Website: https://signalement.social-sante.gouv.fr/.



Overdose

No cases of overdose have been reported.



Pharmacodynamics

Pharmacotherapeutic class: Antiseptic nasal preparation, ATC code: R: respiratory system.



Shelf life

3 years.



Special storage precautions

No special precautions for storage.



SPECIAL PRECAUTIONS FOR DISPOSAL AND OTHER HANDLING

No special requirements.



Prescription, supply and reimbursement

Marketing authorisation (AMM)
CIP 3400934825774 (Bottle of 15 mL).
Not reimbursed by Social Security.

Urgo Healthcare
12 RUE DAUPHINE
21000 DIJON
Tel: 03 80 54 50 00 https://urgo.fr/

Source: VIDAL · Updated on 11/11/2026. This information does not replace advice from a healthcare professional.